Creator: Troester, Melissa A, Herschkowitz, Jason I, Oh, Daniel S., He, Xiaping, Hoadley, Katherine, Barbier, Claire S, Perou, Charles
Abstract Background Breast cancer subtypes identified in genomic studies have different underlying genetic defects. Mutations in the tumor suppressor p53 occur more frequently in estrogen receptor (ER) negative, basal-like and HER2-amplified tumors (more)
pdf (1 MB)
Additional file 1 Microsoft Excel spreadsheet (196 kB) containing lists of genes for which expression levels were significantly associated with p53 loss (in 2-class SAM analyses).
Collection: BioMed Central
Date Deposited: 2016-07-08
Date Created: 2016-07-08
xls (196 KB)